PRECISION: Prospective Randomized Evaluation of Celecoxib Integrated Safety vs Ibuprofen Or Naproxen-A Randomized, Double Blind, Parallel-Group Study of Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthritis Patients with or High Risk for Cardio

Project: Other project

StatusFinished
Effective start/end date2/7/076/30/18

Funding

  • Pfizer, Inc.: $21,484.00